Optimization of in vitro conditions for bovine subcutaneous and ...

4 downloads 0 Views 282KB Size Report
kg; s.c. fat thickness adjacent to the 12th rib, 12.7 to ... Incisions were made dorsal to the 12th and 13th rib, and .... the method described by Adams et al. (1997).
Optimization of in vitro conditions for bovine subcutaneous and intramuscular preadipocyte differentiation1 A. C. Grant,*2 G. Ortiz-Colo`n,*3 M. E. Doumit,*† and D. D. Buskirk*4 *Departments of Animal Science, and †Food Science and Human Nutrition, Michigan State University, East Lansing 48824-1225

ABSTRACT: The objective of these experiments was to develop an in vitro cell culture system for differentiation of bovine preadipocytes, which will permit examination of differences in differentiation between intramuscular (i.m.) and subcutaneous (s.c.) bovine preadipocytes. Stromal-vascular cells from bovine i.m. and s.c. adipose depots were isolated and cultured. Clonally derived s.c. preadipocytes were used to determine the ability of insulin, bovine serum lipids, octanoate, acetic acid, dexamethasone (DEX), and troglitazone (TRO) to elicit differentiation of these cells when added to serumfree medium. Addition of 10 and 20 ␮L/mL of a commercially available serum lipids supplement to low-glucose Dulbecco’s modified Eagle’s medium containing 280 nM insulin increased glycerol-3-phosphate dehydrogenase (GPDH) activity (P < 0.01). Inclusion of 1.25 to 10 ␮M TRO to medium containing 280 nM insulin and 20 ␮L/ mL serum lipids supplement also increased GPDH activity (P < 0.001) compared with 0 ␮M TRO. The combination of 280 nM insulin, 1 mM octanoate, and 10 mM acetic acid, with 48 h exposure to 0.25 ␮M DEX caused

morphological differentiation in a small number of cells but did not stimulate GPDH activity (P = 0.99). When used together, 280 nM insulin, 20 ␮L/mL of serum lipids supplement, 40 ␮M TRO, and 0.25 ␮M DEX stimulated differentiation compared with the aforementioned treatment (P < 0.001). Omission of TRO or insulin from this medium reduced GPDH activity by 68% (P < 0.001), whereas removal of DEX tended to reduce GPDH activity (P = 0.06). Preadipocytes from s.c. (n = 3) and i.m. (n = 2) adipose tissues of 3 steers were used to determine the effects of TRO on differentiation using the established conditions. Forty to sixty ␮M TRO enhanced differentiation compared with 0 ␮M TRO (P < 0.02) in both depots. No depot differences in response to TRO were detected (P = 0.32). These data demonstrate that bovine preadipocytes are capable of differentiation in response to combinations of insulin, serum lipids, DEX, and TRO. Although TRO enhanced differentiation of bovine preadipocytes, no differential effects of TRO on the differentiation of s.c. and i.m. cells were detected.

Key words: bovine, differentiation, glycerol-3-phosphate dehydrogenase, preadipocyte, thiazolidinedione ©2008 American Society of Animal Science. All rights reserved.

INTRODUCTION

J. Anim. Sci. 2008. 86:73–82 doi:10.2527/jas.2007-0379

differentiation. However, differences in development of these cells among adipose depots in cattle are poorly understood. Preadipocyte differentiation is a transformation from a fibroblast-like cell to a lipid-filled cell, with the expression of transcription factors, genes, and enzymes indicative of a mature fat cell (Butterwith, 1994; Gre´goire et al., 1998). Limited research with bovine stromalvascular cells (Sato et al., 1996; Torii et al., 1998) and a clonally derived preadipocyte cell line from Japanese Black cattle (Aso et al., 1995) has shown these cells to be capable of differentiation in response to adipogenic stimuli. However, limited information is available on the culture conditions for optimum bovine preadipocyte differentiation. Wu et al. (2000) demonstrated that bovine omental stromal-vascular cells exhibit a greater relative increase in differentiation when exposed to a peroxisome

Insufficient i.m. adipose and excessive s.c. adipose are paramount beef quality challenges (Roeber et al., 2002; Smith et al., 2006). The amount of adipose in an animal is a function of preadipocyte proliferation and

1 This research was supported by the Michigan Agricultural Experiment Station and was partially funded through a grant from the Michigan Animal Industry Coalition. The authors thank J. Scheffler and C. Allison for laboratory assistance and E. Helman for assistance with sample collection. 2 Current address: Nutrition Service Associates, PO Box 839, Okotoks, Alberta, T1S1A9, Canada. 3 Current address: PO Box 508, Mayaguez, Puerto Rico 00681. 4 Corresponding author: [email protected] Received June 25, 2007. Accepted September 27, 2007.

73

74

Grant et al.

proliferator-activated receptor (PPAR)-γ agonist than s.c. cells. Given that ruminant s.c. stromal-vascular cells may have a greater intrinsic ability to produce natural PPAR-γ ligands compared with stromal-vascular cells of other depots (Soret et al., 1999; Wu et al., 2000), we hypothesized that an exogenous PPAR-γ agonist would enhance the differentiation of bovine i.m. and s.c. preadipocytes, with the relative response being greater in i.m. than s.c. cells. The objectives of these experiments were to 1) establish a protocol for isolation of bovine preadipocytes from economically important depots; 2) establish differentiation conditions using insulin, fatty acids, serum lipids, glucocorticoids, and troglitazone (TRO); and 3) use these conditions to determine differential responses of i.m. and s.c. preadipocytes to TRO.

MATERIALS AND METHODS Animal care was conducted according to procedures approved by the Michigan State University Committee on Animal Use and Care. Bovine stromal-vascular cells isolated from s.c. and i.m. adipose depots were used to determine the effects of adipogenic stimuli on adipose differentiation. Unless otherwise stated, all reagents were of tissue culture grade and were purchased from Sigma (St. Louis, MO).

Stromal-vascular Cell Isolation Subcutaneous and i.m. adipose tissues were collected from 3 Angus steers (age, 13.5 mo; HCW, 345 to 350 kg; s.c. fat thickness adjacent to the 12th rib, 12.7 to 21.6 mm). Before slaughter, steers were fed a cornbased diet for 209 to 249 d. Anabolic implants (200 mg of progesterone and 20 mg of estradiol benzoate) were administered on d 30 and 100 of the feeding period. Adipose tissue samples were collected from the left side of the carcass immediately after exsanguination. Incisions were made dorsal to the 12th and 13th rib, and an approximately 10 cm3 sample containing a portion of both s.c. adipose tissue and LM was obtained. Upon collection, samples were immediately placed in a sterile ice-cold solution of PBS (171.1 mM sodium chloride, 3.4 mM potassium chloride, 10.1 mM sodium phosphate, and 1.8 mM potassium phosphate, pH 7.2) and transported to the laboratory. Stromal-vascular cells from s.c. and i.m. adipose tissues were isolated under sterile conditions using a modification of the method described by Forest et al. (1987). Briefly, s.c. adipose tissue was separated from the LM and visible collagenous connective tissue. Visible connective and muscle tissues were carefully dissected away from i.m. adipose tissue. All excised adipose samples were then cut into approximately 2-mm3 sections. For each depot, samples of approximately 3 g were aliquoted into 50-mL conical tubes and digested in 6 mL of Dulbecco’s modified Eagle’s medium (DMEM; 5.5 mM glucose; Invitrogen Corp., Carlsbad, CA) con-

taining 2 mg/mL of collagenase (C6885, >125 collagenase digestion units/mg of solid) and 2% BSA. Initially, samples were incubated in a 37°C water bath, with inversion of the vials at 0, 5, 10, and 15 min. Each sample was then transferred to an incubator (LabLine Instruments Inc., Melrose Park, IL) and further digested with shaking for 45 min at 37°C and 230 rpm. Digested material was then sequentially filtered through 1,000-, 500-, and 53-␮m sterilized nylon mesh (Nitrex, Tetko, Briarcliff Manor, NY). The resultant filtrate was centrifuged at 4°C for 10 min at 800 × g, the cell pellet was suspended in DMEM, and the centrifugation was repeated. The resulting cell pellet was resuspended in growth medium comprising base medium [DMEM, antibiotic-antimycotic (100 units of penicillin, 0.1 mg of streptomycin, and 0.25 ␮g of amphotericin B per mL), 50 ␮g/mL of gentamicin sulfate, 33 ␮M biotin, 17 ␮M pantothenate, and 100 ␮M ascorbate], supplemented with 10% fetal bovine serum for subsequent cloning.

Preadipocyte Cloning One gram of tissue-equivalent of cells from each depot was suspended in 4 mL of growth medium and seeded equally into 2 wells of a 6-well tissue culture plate (35-mm diam.; Corning Inc., Corning, NY). Cells were incubated at 37°C in a humidified atmosphere of 95% air and 5% CO2, and growth medium was replaced every 2 d. Cells were grown to approximately 70% confluence, washed twice with PBS, and then removed from the wells by trypsinization [0.5 g/L of trypsin and 0.02 g/L of EDTA in PBS (pH 7.2)]. Cell clones were developed using a cloning-ring procedure (Doumit et al., 1993). Cells were counted, diluted, and plated at a density of 400 cells/10-cm culture plate and incubated undisturbed in growth medium for 10 to 14 d. Individual colonies were isolated using 0.5- to 1.0-cm diam. sterile glass cloning-rings dipped in silicone grease. After placement of the cloning rings, cells of a colony were washed twice with PBS, trypsinized, and transferred into one 16-mm diam. culture well containing growth medium. Isolated clones were then grown to approximately 70% confluence in 16-mm diameter and then 35 mm-diameter culture wells, with fresh media changes every 2 d. Cells were then trypsinized, counted using a hemocytometer, and resuspended in freezing media (base medium supplemented with 20% fetal bovine serum and 10% dimethyl sulfoxide). Cells were aliquoted into 1.8-mL cryogenic vials and placed in a styrofoam rack overnight at −80°C, with subsequent storage in liquid nitrogen.

Identification of Preadipocyte Clones Subsamples of cells from each isolated clone were suspended in 10 mL of growth medium and seeded at clonal densities (400 cells/well) in 10-cm plates to determine if the cells were adipogenic. In initial characteriza-

Bovine preadipocyte differentiation

tions, cells were grown for 8 to 10 d to allow distinct colonies to form, then exposed to differentiation medium consisting of base medium supplemented with 8.7 nM bovine insulin, 20 mM glucose, 1 mM octanoate, and 10 mM acetic acid (EMD Chemicals Inc., Gibbstown, NJ), with addition of 0.25 ␮M dexamethasone (DEX) for the first 48 h of the differentiation period. Differentiation medium similar to that stated above stimulated differentiation in an i.m. preadipocyte cell line derived from Japanese Black cattle (Aso et al., 1995). After implementation of improved conditions for bovine preadipocyte differentiation in our laboratory, as more fully described later, cells were grown for 8 to 10 d and induced to differentiate in base media containing 280 nM bovine insulin, 20 mM glucose, and 10 ␮L/mL of bovine serum lipids supplement (Ex-Cyte, Serologicals Corp., Norcross, GA) with 48 h exposure to 0.25 ␮M DEX. The bovine serum lipids culture media supplement was an aqueous lipoprotein concentrate containing a mixture of fatty acids (9.3 mg/mL), cholesterol, and phospholipids, derived from bovine serum (Ex-Cyte, Serologicals Corp.). After 10 to 12 d of exposure to differentiation media, all plates were stained with oil red O as described by Humason (1972) and visualized for the percentage of colonies containing triacylglycerol. A solution of nuclear stain was made by dissolving 1 g of giemsa into 66 mL of glycerol and 66 mL of methanol and filtering through Whatman #1 filter paper. Wells were initially aspirated of media and washed twice with PBS. Cells were then fixed with 3.7% formaldehyde (diluted from a formalin stock; Mallinckrodt Baker Inc., Phillipsburg, NJ) in PBS for 4 min. After fixation, cells were washed twice with PBS and incubated at room temperature with oil red O solution for 1 h. Residual oil red O solution was aspirated and the cells were washed twice with distilled water (15 min incubation/wash). Cell nuclei were stained by adding 1 mL of giemsa solution to each well for 1 h, after which the cells were washed twice in distilled water. Wells were aspirated of water and stored at 4°C. Cells were visualized within 24 h of staining. Digital photographs were taken using a Nikon CoolPix 5000 digital camera (Nikon Inc., Melville, NY) fitted to a Zeiss inverted microscope (Carl Zeiss Inc., Thornwood, NY). Clones having at least 1 cell/colony stained with oil red O in ≥85% of their colonies were characterized as preadipocytes. Clones identified as preadipocytes were seeded at 1,800 cells/cm2 into 10-cm diameter culture plates and sequentially propagated to approximately 70% confluence (5 to 7 d each) until reaching the eighth or ninth passage, at which the cells were used for experimental purposes.

General Procedures Cell Culture. Stromal-vascular cells or clonally derived preadipocytes were seeded in 6-well plates at a density of 5,200 cells/cm2 and incubated in growth medium at 37°C in a humidified atmosphere of 95% air

75

and 5% CO2. After 24 h, plates were washed twice with PBS and fresh growth medium was added. Growth medium was replaced every 2 d until cells reached confluence. After the cells reached confluence, the plates were washed twice with PBS and experimental differentiation treatments applied. For all experiments, differentiation media were replaced with fresh media every 2 d for 10 to 12 d. Treatment media additions were present for the entire differentiation period, except DEX, which was supplemented only for the initial 48 h. All wells were washed twice with PBS before media replacement on d 2 of the differentiation period. To optimize differentiation conditions, 1 s.c. clone (MSU-SC3-C31) developed with the methods described herein and possessing a rapid growth rate and high differentiation potential was used.

Glycerol-3-phosphate Dehydrogenase Activity Assay. Cell differentiation was quantified biochemically by measuring glycerol-3-phosphate dehydrogenase (GPDH) enzyme activity using a modification of the method described by Adams et al. (1997). Cells were washed twice with ice-cold PBS. Cells from 2 wells per treatment were harvested by scraping and combined in a total volume of 200 ␮L of ice-cold Tris (pH 7.4) containing 1 mM EDTA and 50 ␮M dithiothreitol (extraction buffer), then transferred into prechilled 1.5mL microcentrifuge tubes. Each sample was then disrupted by sonication 3 times at 40 W (3 s bursts with 1 min of cooling on ice between bursts) using a SonifierCell Disrupter 350 (Branson Sonic Power Co., Danbury, CT). Samples were then centrifuged at 16,000 × g for 15 min at 2°C. Solutions containing 50 ␮L of the resulting supernatant and 150 ␮L of assay buffer were assayed in duplicate within 30 min for GPDH activity. The final concentration of the supernatant and assay buffer solution was: 100 mM triethanolamine-HCl (pH 7.4), 2.5 mM EDTA, 50 ␮M dithiothreitol, 0.8 mM dihydroxyacetone phosphate, and 0.317 mM NADH. Each reaction was initiated by the addition of assay buffer to the supernatant in 1 well of a 96-well plate (Immulon 1B, Fisher Scientific, Hampton, NH). Extraction buffer (50 ␮L) served as the reagent blank. To obtain the reaction rate, the ⌬A340 was recorded at 15-s intervals for 6 min at 30°C using a spectrophotometer (Versamax Tunable Microplate Reader, Molecular Devices, Sunnyvale, CA). All reactions measured were linear for at least 220 s. The GPDH activity was calculated from the linear range and expressed as nanomoles of NADH oxidizedⴢmin−1ⴢmg of protein−1. Protein Quantification. Aliquots (20 ␮L) of supernatant were assayed in duplicate to determine protein concentration using the bicinchoninic acid assay (BCA Protein Assay Reagent Kit, Pierce, Rockford, IL). Samples were mixed with 200 ␮L of assay reagent, incubated for 30 min at 37°C, and absorbance at 562 nm was determined. Protein concentration was determined using BSA as a standard.

76

Grant et al.

Experiment 1 This experiment was conducted to determine the effect of increasing concentrations of serum lipids on preadipocyte differentiation. Three independent experiments were performed using differentiation media consisting of base medium supplemented with 280 nM bovine insulin, 20 mM glucose, and 0, 5, 10, 20, or 40 ␮L/mL of bovine serum lipids supplement. Protein concentrations and GPDH activities were measured after a 12-d differentiation period.

Experiment 2 To evaluate the adipogenic effects of TRO, a thiazolidinedione PPAR-γ agonist, 2 independent experiments were performed using differentiation media consisting of base medium supplemented with 280 nM bovine insulin, 20 mM glucose, 20 ␮L/mL of serum lipids supplement, and 5, 10, 20, 40, or 60 ␮M TRO (Calbiochem, La Jolla, CA). Troglitazone was solubilized in dimethyl sulfoxide at a stock concentration of 22.7 mM before addition to media. Addition of dimethyl sulfoxide to differentiation media alone did not significantly affect differentiation (data not shown). Protein concentrations and GPDH activities were measured after a 10d differentiation period.

Experiment 3 This experiment was designed to examine the contribution of individual serum-free media components to preadipocyte differentiation. Three independent experiments were performed with differentiation media treatments consisting of base medium with 20 mM glucose, supplemented with: 280 nM bovine insulin, 0.25 ␮M DEX, 1 mM octanoate, and 10 mM acetic acid (TRT 1); 280 nM bovine insulin, 20 ␮L/mL of serum lipids supplement, and 0.25 ␮M DEX (TRT 2); 280 nM bovine insulin, 20 ␮L/mL of serum lipids supplement, 0.25 ␮M DEX, and 40 ␮M TRO (TRT 3); 280 nM bovine insulin, 20 ␮L/mL of serum lipids supplement, and 40 ␮M TRO (TRT 4); or 20 ␮L/mL serum lipids supplement, 0.25 ␮M DEX, and 40 ␮M TRO (TRT 5). Protein concentrations and GPDH activities were measured after a 12d differentiation period.

Experiment 4 The effects of TRO on differentiation of s.c. and i.m. stromal-vascular cells from 3 steers were compared. Differentiation media consisted of base medium supplemented with 280 nM bovine insulin, 20 mM glucose, 20 ␮L/mL of serum lipids supplement, and 5, 10, 20, 40, or 60 ␮M TRO. Protein concentrations and GPDH activities were measured after a 12-d differentiation period.

Statistical Analysis Data were analyzed using the mixed model procedure (PROC MIXED) of SAS (SAS Inst. Inc., Cary, NC) as

Figure 1. Effect of serum lipids supplement (Ex-Cyte, Serologicals Corp., Norcross, GA) on glycerol-3-phosphate dehydrogenase (GPDH) activity and protein concentration of subcutaneous bovine clonally derived preadipocytes. The effect was quadratic (P < 0.01). Values are least squares means and SEM of 3 independent experiments. a,b, x–zLeast squares means without a common superscript letter differ (P < 0.05).

appropriate for completely randomized designs. Experiments 1, 2, and 3 were conducted with a s.c. clone and Exp. 4 was conducted with stromal-vascular cells derived from both the s.c. and i.m. tissues from 3 steers. Data from triplicate (Exp. 1, 3, 4) or duplicate (Exp. 2) experiments were analyzed, and pooled cells from 2 wells of a 6-well plate were considered the experimental unit. In Exp. 4, each replicate consisted of cells from a different animal. In Exp. 1, 2, and 3, means were calculated using the fixed effects of serum lipids supplement, TRO, and treatment, respectively. In Exp. 4, to satisfy the conditions of normality and homogeneity of variance, GPDH data were ln-transformed. Least squares means were computed for the fixed effects of TRO, depot, and TRO × depot. Steer within depot and TRO × steer within depot were included as random effects and were defined as the experimental units for depot and TRO, respectively. For Exp. 1, 2, and 4, linear and quadratic regression models for dose responses were determined using the PROC REG procedure of SAS. In all experiments, when main effects were considered significant (P < 0.05), differences between means were investigated using Tukey’s multiple comparison test.

RESULTS AND DISCUSSION Addition of serum lipids to serum-free differentiation media for 12 d had a quadratic effect (P < 0.01) on GDPH activity (Figure 1). Preadipocyte differentiation was not detected using control media without serum lipids. However, cells containing lipid droplets were

Bovine preadipocyte differentiation

observed with the addition of 5 ␮L/mL or greater serum lipids supplement, and concentrations of 10 and 20 ␮L/ mL serum lipids supplement (P < 0.01) increased GPDH activity compared with the control, but did not differ from each other (P = 0.37). Inclusion of 40 ␮L/mL serum lipids supplement showed no difference in GPDH activity (P = 0.99) compared with the control. Cell morphology and viability appeared to be negatively affected with addition of 40 ␮L/mL of serum lipids supplement (unpublished observations). Previous studies using bovine (Wu et al., 2000) and ovine (Soret et al., 1999) stromal-vascular cells have shown that lipid supplementation enhances differentiation. Wu et al. (2000) demonstrated that addition of a lipid emulsion (containing phosphatidylcholine and triacylglycerols) to differentiation media stimulated differentiation of stromal-vascular cells extracted from Japanese Black steers. Also, the inclusion of very low-, low-, or high-density lipoproteins, derived from human plasma, enhanced adipose conversion. Using the same serum lipids source used in our experiments, Soret et al. (1999) showed that 10 ␮L/mL of serum lipids supplement stimulated lipid accumulation in ovine stromalvascular cells. Fatty acids, especially long chain PUFA, serve as substrates for esterification to triacylglycerol and phospholipids, or stimulate preadipocyte differentiation through ligand binding to PPAR, or both (Kliewer et al., 1997; Krey et al., 1997). Of note, linoleic acid has been found to increase lipid accumulation in human (Hutley et al., 2003) and porcine (Ding et al., 2003) stromal-vascular cells. Likewise, arachidonic acid has been found to enhance differentiation in the Ob1771 preadipocyte cell line (Massiera et al., 2003) and may exert its effects via its eicosanoid products (Krey et al., 1997), including the prostaglandins (Kliewer et al., 1997; Massiera et al., 2003). Expression of PPAR-γ protein has been documented in undifferentiated bovine (Torii et al., 1998) and porcine (Kim et al., 2000) stromal-vascular cells derived from adipose tissue. Ding et al. (2003) suggested that addition of PPAR-γ ligands, such as fatty acids (FA), stimulate differentiation in porcine stromal-vascular cells through ligand binding to PPAR-γ, as well as potentially serving as substrates for triacylglycerol synthesis. These mechanisms would explain the observed increase in differentiation of bovine s.c. preadipocytes due to addition of serum lipids. Increasing concentrations of TRO, previously shown to stimulate differentiation in stromal-vascular cells isolated from Japanese Black cattle (Ohyama et al., 1998; Torii et al., 1998), were added to our differentiation media in an attempt to increase adipogenesis of bovine s.c. preadipocytes. A quadratic increase in GPDH activity (P < 0.0001) was observed with increasing concentrations of TRO (Figure 2). There were no significant differences in GPDH activity among treatments of 20 ␮M or greater TRO. Addition of 20 to 60 ␮M TRO increased GPDH activity by 5-fold compared with control (P < 0.001). Similarly, Soret et al. (1999) reported a 1.9- to 2.5-fold increase in GPDH activity

77

Figure 2. Effect of troglitazone supplementation on glycerol-3-phosphate dehydrogenase (GPDH) activity of subcutaneous bovine clonally derived preadipocytes. The effect was quadratic (P < 0.0001). Values are least squares means and SEM of 3 independent experiments. a–cLeast squares means without a common superscript letter differ (P < 0.05).

of stromal-vascular cells derived from 6- to 8-mo-old wether lambs when 100 nM rosiglitazone (another thiazolidinedione) was added to media containing 10 ␮L/ mL of serum lipids supplement. The concentrations of TRO found to stimulate differentiation in our experiment were within the range of TRO (1 to 100 ␮M) previously shown to enhance adipose conversion of perirenal (Ohyama et al., 1998) and i.m. (Torii et al., 1998) stromal-vascular cells isolated from Japanese Black cattle. Thiazolidinediones such as TRO, are known to be high affinity PPAR-γ ligands (Lehmann et al., 1995). Expression of PPAR-γ is primarily in adipose tissues of most species investigated (Chawla et al., 1994; Braissant et al., 1996; Sundvold et al., 1997), including cattle (Torii et al., 1998), and has been implicated in the differentiation process through its activation by endogenous (Kliewer et al., 1997; Krey et al., 1997) and synthetic (Lehmann et al., 1995; Spiegelman, 1998) ligands. Ligand-bound PPAR-γ forms heterodimers with retinoid × receptors, which are then capable of binding to PPAR response elements in the promoters of adipogenic genes, thus stimulating differentiation (Kliewer et al., 1992). Inclusion of serum lipids in our differentiation media stimulated differentiation of bovine preadipocytes, and a PPAR-γ agonist induced additional increases in GPDH activity. This increase in differentiation was likely a result of TRO being a more potent activator of PPAR-γ than the FA in serum lipids. Enhanced ligand binding to PPAR-γ may increase adipogenic gene transcription, thus stimulating a greater number of cells to

78

Grant et al.

differentiate or increase the adipogenic capacity of the differentiated cells, or both. Therefore, whereas TRO likely acted as the more potent PPAR-γ agonist, serum lipids may have contributed to differentiation as a source of FA for membrane phospholipid synthesis, a substrate for triacylglycerol synthesis, or both. Octanoate (Aso et al., 1995; Sato et al., 1996; Wu et al., 2000) and acetate (Aso et al., 1995) have previously been incorporated into differentiation media of bovine stromal-vascular cells and preadipocytes, respectively. When used in combination with DEX and 1-methyl-3isobutylxanthine, Sato et al. (1996) found that octanoate stimulated a 5-fold increase in GPDH activity using bovine i.m. stromal-vascular cells, whereas Wu et al. (2000) observed no significant response in omental cells. Han et al. (2002) suggested that octanoate may serve as a PPAR-γ ligand and possibly activate differentiation in the 3T3-L1 cell line. Acetate is considered the major precursor for FA synthesis in ruminant adipose tissues (Vernon, 1980), and Aso et al. (1995) showed increased acetate incorporation into bovine clonal preadipocytes during adipose accumulation following differentiation. The combination of 1 mM octanoate and 10 mM acetic acid with 0.25 ␮M DEX, and 280 nM insulin (TRT 1) resulted in the morphological differentiation of a small number of cells (Figure 3). However, these FA did not induce GPDH activity (Figure 4) in the bovine s.c. preadipocytes. Lipid emulsions have also been shown to enhance stromal-vascular cell differentiation (Soret et al., 1999; Wu et al., 2000). Replacing octanoate and acetate with serum lipids was sufficient to generate GPDH activity (Figure 4), as well as visually increase the number of morphologically differentiated cells. In addition, a 1.7fold increase in protein concentration was observed when serum lipids replaced octanoate and acetate, indicating that the supplement was more favorable for both cell viability and differentiation. The concentration of FA in the serum lipids supplement (0.19 mg/mL) used in this study was within the concentration range of octanoate (0.14 mg/mL) and acetate (0.60 mg/mL) provided to the cells in TRT 1. We did not determine if the short chain fatty acids inhibit adipogenesis or were simply insufficient to stimulate adipogenesis. The combination of TRO, DEX, serum lipids supplement, and insulin resulted in the greatest GPDH activity (TRT 3, Figure 4). Omission of DEX (TRT 4) tended to reduce GPDH activity (P = 0.06), whereas the removal of TRO (TRT 2) decreased GPDH activity by 68% (P < 0.001) and also reduced protein concentrations (P = 0.03). Wu et al. (1996) suggested that glucocorticoids are capable of increasing differentiation through the upregulation of CCAT/enhancer-binding proteins, which in turn, influence the expression of PPAR-γ in the 3T3-L1 cell line. Also, glucocorticoids may increase differentiation through the enhancement of arachidonic acid metabolism (Gaillard et al., 1991). Thus, the potential for synergism between DEX and TRO in enhancing differentiation exists. Soret et al. (1999) found the com-

Figure 3. Representative photomicrographs of subcutaneous bovine clonally derived preadipocytes exposed for 12 d to: (A) serum-free differentiation medium supplemented with 280 nM insulin, 0.25 ␮M dexamethasone, 1 mM octanoate, and 10 mM acetate (TRT 1); or (B) to serum-free differentiation medium supplemented with 280 nM insulin, 20 ␮L/mL of serum lipids supplement (Ex-Cyte, Serologicals Corp., Norcross, GA), and 40 ␮M troglitazone (TRT 4). Cells are stained with oil red O and lightly counterstained with giemsa. Bar = 100 ␮m. bination of DEX and a thiazolidinedione to be additive in stimulating the differentiation of stromal-vascular cells from 6- to 8-mo-old wether lambs. However, results using stromal-vascular cells from suckling lambs (Soret et al., 1999), and those from 5- to 7-d-old pigs (Tchoukalova et al., 2000) demonstrated that the combination of DEX and a thiazolidinedione did not stimulate differentiation above that of either compound when included individually. Soret et al. (1999) therefore suggested that the effects of these compounds on stromal-vascular cell differentiation are dependent on species, depot, and animal age. In addition, Soret et al. (1999) also found

Bovine preadipocyte differentiation

79

Figure 4. Effect of adipogenic agents on glycerol-3-phosphate dehydrogenase (GPDH), activity and protein concentration of subcutaneous bovine clonally-derived preadipocytes. Components included (+) in or excluded (−) from the media were troglitazone (TRO; 40 ␮M), dexamethasone (DEX; 0.25 ␮M), serum lipids supplement (SL; Ex-Cyte, Serologicals Corp., Norcross, GA) (20 ␮L/mL), insulin (280 nM), octanoate (1 mM), and acetate (10 mM). Values are least squares means and SEM of 3 independent experiments. a–c, x–zLeast squares means without a common superscript letter differ (P < 0.05). that DEX and a thiazolidinedione increased protein concentrations individually, and in combination with serum lipids. Based on the reduced activity observed upon their removal from media, our study suggests that TRO was a more potent stimulator of differentiation than DEX. Insulin appeared to enhance adipose differentiation, viability, or both of the s.c. preadipocytes, because a 74% reduction in GPDH activity (P < 0.001) was recorded upon omission of insulin from differentiation media (TRT 5, Figure 4). Insulin is known to stimulate adipogenesis of swine (Suryawan et al., 1997) and ovine (Adams et al., 1996) stromal-vascular cells and has been included in differentiation media of bovine stromal-vascular cells and preadipocytes (Aso et al., 1995; Torii et al., 1998; Wu et al., 2000). Adams et al. (1996) documented that exclusion of insulin from differentiation media prevented the adipogenesis of ovine stromal-vascular cells. Although the specific effects of insulin on preadipocyte differentiation have yet to be fully detailed, insulin has been shown to influence the expression of adipogenic genes. Insulin enhanced the transcription of genes such as fatty acid synthase (Moustaid et al., 1994; Paulauskis and Sul, 1988), glyceraldehyde3-phosphate dehydrogenase (Nasrin et al., 1990), acylCoA synthetase, and stearoyl CoA desaturase-1

(Weiner et al., 1991), in studies using the 3T3-L1 cell line. Insulin also stimulates glucose uptake into 3T3L1 adipocytes through increased translocation of the glucose transporter-4 protein to the plasma membrane (Calderhead et al., 1990). In addition, Stahl et al. (2002) showed that insulin increased cellular uptake of long chain FA through stimulating FA transport protein translocation from intracellular pools to the plasma membrane in 3T3-L1 adipocytes. Therefore, insulin may act as a modulator of cellular differentiation, as well as serve to increase substrate availability for adipogenesis in adipocytes. This suggests that the lack of insulin may have reduced glucose uptake or FA entry into the cells, which in turn reduced GPDH activity. The exclusion of insulin also caused a reduction in protein concentration (P < 0.001) compared with TRT 2, 3, or 4, and apparently reduced viability of these bovine preadipocytes. Ursø et al. (2001) demonstrated that apoptosis is inhibited in 3T3-L1 fibroblasts and adipocytes via the intracellular domains of both the insulin and IGF type I receptor. Removal of the serum lipids supplement from TRT 3 (Figure 4) resulted in substantial cell detachment from the plates 2 d after exposure to differentiation media (unpublished observations). The serum lipids supplement appeared to contain components that aided in

80

Grant et al.

Figure 5. Effect of troglitazone supplementation on glycerol-3-phosphate dehydrogenase (GPDH) activity. The effect was linear (P < 0.01). Values are least squares means and SEM for 2 independent experiments using subcutaneous and intramuscular bovine stromal-vascular cells from 3 steers. a,bLeast squares means without a common superscript letter differ (P < 0.05). Because there were no depot effects or depot × treatment interactions (P > 0.30), the data were pooled. Inset shows the results for the subcutaneous (SC) and intramuscular (IM) bovine stromal-vascular cells; the axis labels are the same. maintaining cell viability, attachment, or both during differentiation. The latter appears to be dependent upon the presence of DEX, TRO, or both, because medium containing no serum lipids supplement was capable of supporting cell viability in the absence of DEX and TRO (Figure 1). To examine if the adipogenic effect of TRO was depotspecific, we exposed stromal-vascular cells derived from both i.m. and s.c. adipose tissues to increasing concentrations of TRO. Increasing concentrations of TRO caused a dose-dependent linear increase in GPDH activity in both depots (P < 0.01), and no depot effects (P = 0.32) or depot × treatment interactions (P = 0.69) were detected. Pooled data are shown in Figure 5 and results for each depot are shown in the Figure 5 inset. Addition of 40 or 60 ␮M TRO increased GPDH activity

2.9- and 3.4-fold, respectively, compared with control (P < 0.02). The conditions established with clonally derived s.c. preadipocytes were suitable for differentiation of s.c. and i.m. stromal-vascular cells. Additionally, clonally derived preadipocytes and heterogeneous stromalvascular cells responded similarly to TRO (Figures 2 and 5). Despite the lack of a depot effect on GPDH, bovine s.c. stromal-vascular cells appear to accumulate more lipid than bovine i.m. stromal-vascular cells. This observation warrants further investigation and refutes our hypothesis that an exogenous PPAR-γ agonist would enhance the differentiation of bovine i.m. and s.c. preadipocytes, with the relative response being greater in i.m. than s.c. cells. Previous studies using stromal-vascular cells isolated from 6- to 8-mo-old wether lambs (Soret et al., 1999)

Bovine preadipocyte differentiation

and 4- to 5-yr-old Holstein cows (Wu et al., 2000) have shown a greater relative increase in GPDH activity in omental compared with s.c. cells with addition of a PPAR-γ agonist to differentiation media. The authors suggested that omental cells might be limited in their ability to produce natural PPAR-γ ligands compared with s.c. cells. In contrast, studies using human stromal-vascular cells have shown that thiazolidinedione addition stimulated differentiation in s.c. cells, whereas omental cells were less responsive to treatment (Adams et al., 1997; Sewter et al., 2002; Tchkonia et al., 2002). Adams et al. (1997) observed no differences in PPARγ protein abundance between depots and offered no definitive explanation for the depot-specific responses to thiazolidinedione. However, more current studies showed that PPAR-γ messenger RNA (Sewter et al., 2002; Tchkonia et al., 2002) and protein expression (Tchkonia et al., 2002) were greater in human s.c. stromal-vascular cells than omental and, thus, may account for depot differences in adipogenesis. When taken together, the aforementioned studies suggest that regional variation in adipogenesis exists in stromal-vascular cells isolated from different depots. Although bovine i.m. and s.c. stromal-vascular cells have been shown to respond to lipid supplements (Sato et al., 1996; Wu et al., 2000) and thiazolidinedione (Torii et al., 1998), this study represents the first direct depot comparison of bovine i.m. and s.c. preadipocytes to a PPARγ ligand. This study established that bovine clonally-derived subcutaneous preadipocytes were capable of increased differentiation in response to serum lipids, DEX, and TRO. As well, the relative increase in differentiation of both s.c. and i.m. preadipocytes was similar when exposed to TRO. This suggests that PPAR-γ is likely involved in the differentiation of both depots. The use of clonally derived preadipocytes enabled the optimization of differentiation conditions, which allowed for the first direct comparison between bovine i.m. and s.c. preadipocytes. This culture system will permit future investigations on the cellular mechanisms involved in bovine adipose tissue development, and elucidation of depot differences in preadipocyte differentiation.

LITERATURE CITED Adams, K. S., D. J. Flint, A. Cryer, and R. G. Vernon. 1996. Regulation of ovine preadipocyte differentiation in vitro. Proc. Nutr. Soc. 55:25A. (Abstr.) Adams, M., C. T. Montague, J. B. Prins, J. C. Holder, S. A. Smith, L. Sanders, J. E. Digby, C. P. Sewter, M. A. Lazar, V. K. K. Chatterjee, and S. O’Rahilly. 1997. Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation. J. Clin. Invest. 100:3149– 3153. Aso, H., A. Hiroyuki, I. Nakajima, K. Ozutsum, T. Yamaguchi, A. Y. Takamori, F. Kodama, B. Hoshino, and S. Takano. 1995. A preadipocyte clonal line from bovine intramuscular adipose tissue: Nonexpression of GLUT-4 protein during adipocyte differentiation. Biochem. Biophys. Res. Commun. 213:369–375. Braissant, O., F. Foufelle, C. Scotto, M. Dauca, and W. Wahli. 1996. Differential expression of peroxisome proliferator-activated re-

81

ceptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137:354–366. Butterwith, S. C. 1994. Molecular events in adipocyte development. Pharmacol. Ther. 61:399–411. Calderhead, D. M., K. Kitagawa, L. I. Tanner, G. D. Holman, and G. E. Lienard. 1990. Insulin regulation of the two glucose transporters in 3T3-L1 adipocytes. J. Biol. Chem. 265:13800–13808. Chawla, A., E. J. Schwarz, D. D. Dimaculangan, and M. A. Lazar. 1994. Peroxisome proliferator-activated receptor (PPAR) γ: Adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798–800. Ding, S. T., J. C. Wang, and H. J. Mersmann. 2003. Effect of unsaturated fatty acids on porcine adipocyte differentiation. Nutr. Res. 23:1059–1069. Doumit, M. E., D. R. Cook, and R. A. Merkel. 1993. Fibroblast growth factor, epidermal growth factor, insulin-like growth factors, and platelet-derived growth factor-BB stimulate proliferation of clonally derived porcine myogenic satellite cells. J. Cell. Physiol. 157:326–332. Forest, C., A. Doglio, D. Ricquier, and G. Ailhaud. 1987. A preadipocyte clonal line from mouse brown adipose tissue. Exp. Cell Res. 168:218–232. Gaillard, D., M. Wabitsch, B. Pipy, and R. Ne´grel. 1991. Control of terminal differentiation of adipose precursor cells by glucocorticoids. J. Lipid Res. 32:569–579. Gre´goire, F. M., C. M. Smas, and H. S. Sul. 1998. Understanding adipocyte differentiation. Physiol. Rev. 78:783–809. Han, J., S. R. Farmer, J. L. Kirkland, B. E. Corkey, R. Yoon, T. Pirtskhalava, Y. Ido, and W. Guo. 2002. Octanoate attenuates adipogenesis in 3T3-L1 preadipocytes. J. Nutr. 132:904–910. Humason, G. L. 1972. Animal Tissue Techniques. Freeman, San Francisco, CA. Hutley, L., F. M. Newell, J. M. Joyner, S. J. Suchting, A. C. Herington, D. P. Cameron, and J. B. Prins. 2003. Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation. Eur. J. Clin. Invest. 33:574–581. Kim, H. S., G. J. Hausman, D. B. Hausman, R. J. Martin, and R. G. Dean. 2000. The expression of peroxisome proliferator-activated receptor γ in pig fetal tissue and primary stromal-vascular cultures. Obes. Res. 8:83–88. Kliewer, S. A., S. S. Sundseth, S. A. Jones, P. J. Brown, G. B. Wisely, C. S. Koble, P. Devchand, W. Wahli, T. M. Willson, J. M. Lenhard, and J. M. Lehmann. 1997. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA 94:4318–4323. Kliewer, S. A., K. Umesono, D. J. Noonan, R. A. Heyman, and R. M. Evans. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358:771–776. Krey, G., O. Braissant, F. L’Horset, E. Kalkhoven, M. Perroud, M. G. Parker, and W. Wahli. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependant receptor ligand assay. Mol. Endocrinol. 11:779–791. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferatoractivated receptor g (PPARγ). J. Biol. Chem. 270:12953–12956. Massiera, F., P. Saint-Marc, J. Seydoux, T. Murata, T. Kobayashi, S. Narumiya, P. Guesnet, E. Amri, R. Negrel, and G. Ailhaud. 2003. Arachidonic acid and prostacyclin signalling promote adipose tissue development: A human health concern? J. Lipid Res. 44:271–279. Moustaid, N., R. S. Byer, and H. S. Sul. 1994. Identification of an insulin response element in the fatty acid synthase promoter. J. Biol. Chem. 269:5629–5634. Nasrin, N., L. Ercolani, M. Denaro, X. F. Kong, I. Kang, and M. Alexander. 1990. An insulin response element in the glyceraldehyde-3-phosphate dehydrogenase gene binds a nuclear protein

82

Grant et al.

induced by insulin in cultured cells and by nutritional manipulations in vivo. Proc. Natl. Acad. Sci. USA 87:5273–5277. Ohyama, M., K. Matsuda, S. Torii, T. Matsui, H. Yano, T. Kawada, and T. Ishihara. 1998. The interaction between vitamin A and thiazolidinedione on bovine adipocyte differentiation in primary culture. J. Anim. Sci. 76:61–65. Paulauskis, J. D., and H. S. Sul. 1988. Cloning and expression of mouse fatty acid synthase and other specific mRNA’s. J. Biol. Chem. 263:7049–7054. Roeber, D. L., D. R. McKenna, P. K. Bates, T. B. Schmidt, K. E. Belk, T. G. Field, J. A. Scanga, J. W. Savell, J. B. Morgan, T. H. Montgomery, and G. C. Smith. 2002. The 2000 National Beef Quality Audits: Views of producers, packers, and merchandisers on current quality characteristics of beef. Prof. Anim. Sci. 18:112–119. Sato, K., N. Nakanishi, and M. Mitsumoto. 1996. Culture conditions supporting adipose conversion of stromal-vascular cells from bovine intramuscular adipose tissues. J. Vet. Med. Sci. 58:1073–1078. Sewter, C. P., F. Blows, A. Vidal-Puig, and S. O’Rahilly. 2002. Regional differences in the response of human pre-adipocytes to PPARγ and RXRα agonists. Diabetes 51:718–723. Smith, G. C., J. W. Savell, J. B. Morgan, and T. E. Lawrence. 2006. Executive summary of the 2005 National Beef Quality Audit, Natl. Cattlemen’s Beef Assoc., Centennial, CO. Soret, B., H.-J. Lee, E. Finley, S. C. Lee, and R. G. Vernon. 1999. Regulation of differentiation of sheep subcutaneous and abdominal preadipocytes in culture. J. Endocrinol. 161:517–524. Spiegelman, B. M. 1998. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507–514. Stahl, A., J. G. Evans, S. Pattel, D. Hirsch, and H. F. Lodish. 2002. Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. Dev. Cell 2:477–488. Sundvold, H., A. Brzozowska, and S. Lien. 1997. Characterization of bovine peroxisome proliferator-activated receptors γ1 and γ2: Genetic mapping and differential expression of the two isoforms. Biochem. Biophys. Res. Commun. 239:857–861.

Suryawan, A., L. V. Swanson, and C. Y. Hu. 1997. Insulin and hydrocortisone, but not triiodothyronine, are required for the differentiation of pig preadipocytes in primary culture. J. Anim. Sci. 75:105–111. Tchkonia, T., N. Giorgadze, T. Pirtskhalava, Y. Tchoukalova, I. Karagiannides, R. A. Forse, M. Deponte, M. Stevenson, W. Guo, J. Han, G. Waloga, T. L. Lash, M. D. Jensen, and J. L. Kirkland. 2002. Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am. J. Physiol. 282:R1286– R1296. Tchoukalova, Y. D., D. B. Hausman, R. G. Dean, and G. J. Hausman. 2000. Enhancing effect of troglitazone on porcine adipocyte differentiation in primary culture: A comparison with dexamethasone. Obes. Res. 8:664–672. Torii, S., T. Kawada, K. Matsuda, T. Matsui, T. Ishihara, and H. Yano. 1998. Thiazolidinedione induces the adipose differentiation of fibroblast-like cells resident within bovine skeletal muscle. Cell Biol. Int. 22:421–427. Ursø, B., C. U. Niesler, S. O’Rahilly, and K. Siddle. 2001. Comparison of anti-apoptotic signalling by the insulin receptor and IGF-I receptor in preadipocytes and adipocytes. Cell. Signal. 13:279–285. Vernon, R. G. 1980. Lipid metabolism in the adipose tissue of ruminant animals. Prog. Lipid Res. 19:23–106. Weiner, F. R., P. J. Smith, S. Wertheimer, and C. S. Rubin. 1991. Regulation of gene expression by insulin and tumor necrosis factor α in 3T3-L1 cells. J. Biol. Chem. 266:23525–23528. Wu, Z., N. L. R. Bucher, and S. F. Farmer. 1996. Induction of peroxisome proliferator-activated receptor γ during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids. Mol. Cell. Biol. 16:4128–4136. Wu, P., K. Sato, F. Suzuta, Y. Hikasa, and K. Kagota. 2000. Effects of lipid-related factors on adipocyte differentiation of bovine stromal-vascular cells in primary culture. J. Vet. Med. Sci. 62:933–939.